108 related articles for article (PubMed ID: 18837291)
1. Breast cancer resistance protein expression and 5-fluorouracil resistance.
Yuan JH; Cheng JQ; Jiang LY; Ji WD; Guo LF; Liu JJ; Xu XY; He JS; Wang XM; Zhuang ZX
Biomed Environ Sci; 2008 Aug; 21(4):290-5. PubMed ID: 18837291
[TBL] [Abstract][Full Text] [Related]
2. [Study on the relationship between breast cancer resistance protein expression and 5-fluorouracil resistance].
Yuan JH; Cheng JQ; Ke YB; Ji NN; Zhou JM; Zhou L; Huang HY; Yang LQ; Liu JJ; Xu XY; Zhuang ZX
Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Jul; 42(7):506-10. PubMed ID: 19035187
[TBL] [Abstract][Full Text] [Related]
3. Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
Yuan J; Lv H; Peng B; Wang C; Yu Y; He Z
Cancer Chemother Pharmacol; 2009 May; 63(6):1103-10. PubMed ID: 18820913
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
[TBL] [Abstract][Full Text] [Related]
5. Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.
Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S
Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157
[TBL] [Abstract][Full Text] [Related]
6. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
[TBL] [Abstract][Full Text] [Related]
7. Expression of the breast cancer resistance protein and 5
Wang M; Wang X; Yuan J; Guo L
Mol Clin Oncol; 2013 Sep; 1(5):853-857. PubMed ID: 24649260
[TBL] [Abstract][Full Text] [Related]
8. [Expression establishment and functional analysis of breast cancer resistance protein with doxycycline induced tet regulating system in mouse fibroblast cell line PA317].
Yuan JH; He ZM; Yu YH; Chen ZC
Ai Zheng; 2004 Oct; 23(10):1127-33. PubMed ID: 15473921
[TBL] [Abstract][Full Text] [Related]
9. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
Zhang YH; Li G; Yu J; Xu MS; Liu ZX
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
[TBL] [Abstract][Full Text] [Related]
10. Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase.
Ji N; Yuan J; Liu J; Tian S
Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):854-62. PubMed ID: 21106767
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells.
Zhang W; Ding W; Chen Y; Feng M; Ouyang Y; Yu Y; He Z
Acta Biochim Biophys Sin (Shanghai); 2011 Aug; 43(8):647-53. PubMed ID: 21712253
[TBL] [Abstract][Full Text] [Related]
12. [Expression of serum breast drug-resistance protein in predicting chemosensitivity of NSCLC].
Hu Y; Feng FY; Cheng SJ; Gao YN; Xiao T; Liu YN
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):750-2. PubMed ID: 17366786
[TBL] [Abstract][Full Text] [Related]
13. Expression and functional analyses of breast cancer resistance protein in lung cancer.
Kawabata S; Oka M; Soda H; Shiozawa K; Nakatomi K; Tsurutani J; Nakamura Y; Doi S; Kitazaki T; Sugahara K; Yamada Y; Kamihira S; Kohno S
Clin Cancer Res; 2003 Aug; 9(8):3052-7. PubMed ID: 12912956
[TBL] [Abstract][Full Text] [Related]
14. Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells.
Nakano H; Nakamura Y; Soda H; Kamikatahira M; Uchida K; Takasu M; Kitazaki T; Yamaguchi H; Nakatomi K; Yanagihara K; Kohno S; Tsukamoto K
Cancer; 2008 Mar; 112(5):1122-30. PubMed ID: 18219662
[TBL] [Abstract][Full Text] [Related]
15. [Gene expression of breast cancer resistance protein in adult acute lymphocytic leukemia and its clinical significance].
Jiang XJ; Wang JS; Fang Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):31-4. PubMed ID: 18315895
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of BCRP expression in breast cancer patients].
Maciejczyk A; Szelachowska J; Ekiert M; Matkowski R; Hałoń A; Surowiak P
Ginekol Pol; 2012 Sep; 83(9):681-7. PubMed ID: 23342897
[TBL] [Abstract][Full Text] [Related]
17. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).
Ma MT; He M; Wang Y; Jiao XY; Zhao L; Bai XF; Yu ZJ; Wu HZ; Sun ML; Song ZG; Wei MJ
Cancer Lett; 2013 Oct; 339(1):107-15. PubMed ID: 23879965
[TBL] [Abstract][Full Text] [Related]
18. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship.
Katayama K; Masuyama K; Yoshioka S; Hasegawa H; Mitsuhashi J; Sugimoto Y
Cancer Chemother Pharmacol; 2007 Nov; 60(6):789-97. PubMed ID: 17345086
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia.
Raaijmakers MH; de Grouw EP; Heuver LH; van der Reijden BA; Jansen JH; Scheper RJ; Scheffer GL; de Witte TJ; Raymakers RA
Clin Cancer Res; 2005 Mar; 11(6):2436-44. PubMed ID: 15788695
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.
Benderra Z; Faussat AM; Sayada L; Perrot JY; Chaoui D; Marie JP; Legrand O
Clin Cancer Res; 2004 Dec; 10(23):7896-902. PubMed ID: 15585622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
